150 related articles for article (PubMed ID: 38224447)
1. Effects of Metabolites of Lactobacillus casei on Expression and Neutralization of Shiga Toxin by Enterohemorrhagic Escherichia coli.
Aditya A; Tabashsum Z; Martinez ZA; Biswas D
Probiotics Antimicrob Proteins; 2024 Jan; ():. PubMed ID: 38224447
[TBL] [Abstract][Full Text] [Related]
2. Shiga toxin-mediated hemolytic uremic syndrome: time to change the diagnostic paradigm?
Bielaszewska M; Köck R; Friedrich AW; von Eiff C; Zimmerhackl LB; Karch H; Mellmann A
PLoS One; 2007 Oct; 2(10):e1024. PubMed ID: 17925872
[TBL] [Abstract][Full Text] [Related]
3. Probiotic Escherichia coli Nissle 1917 reduces growth, Shiga toxin expression, release and thus cytotoxicity of enterohemorrhagic Escherichia coli.
Mohsin M; Guenther S; Schierack P; Tedin K; Wieler LH
Int J Med Microbiol; 2015 Jan; 305(1):20-6. PubMed ID: 25465158
[TBL] [Abstract][Full Text] [Related]
4. Shiga toxin in enterohemorrhagic E.coli: regulation and novel anti-virulence strategies.
Pacheco AR; Sperandio V
Front Cell Infect Microbiol; 2012; 2():81. PubMed ID: 22919672
[TBL] [Abstract][Full Text] [Related]
5. Antagonistic Effects of Conjugated Linoleic Acids of Lactobacillus casei against Foodborne Enterohemorrhagic Escherichia coli.
Aditya A; Li Y; Biswas D
J Food Prot; 2022 Apr; 85(4):712-719. PubMed ID: 35113991
[TBL] [Abstract][Full Text] [Related]
6. Therapeutic use of a receptor mimic probiotic reduces intestinal Shiga toxin levels in a piglet model of hemolytic uremic syndrome.
Hostetter SJ; Helgerson AF; Paton JC; Paton AW; Cornick NA
BMC Res Notes; 2014 Jun; 7():331. PubMed ID: 24890228
[TBL] [Abstract][Full Text] [Related]
7. The role of virulence factors in enterohemorrhagic Escherichia coli (EHEC)--associated hemolytic-uremic syndrome.
Karch H
Semin Thromb Hemost; 2001 Jun; 27(3):207-13. PubMed ID: 11446654
[TBL] [Abstract][Full Text] [Related]
8. Vitamin K Analogs Influence the Growth and Virulence Potential of Enterohemorrhagic Escherichia coli.
Kijewski A; Witsø IL; Iversen H; Rønning HT; L'Abée-Lund T; Wasteson Y; Lindbäck T; Aspholm M
Appl Environ Microbiol; 2020 Nov; 86(24):. PubMed ID: 32769190
[TBL] [Abstract][Full Text] [Related]
9. CRISPR Screen Reveals that EHEC's T3SS and Shiga Toxin Rely on Shared Host Factors for Infection.
Pacheco AR; Lazarus JE; Sit B; Schmieder S; Lencer WI; Blondel CJ; Doench JG; Davis BM; Waldor MK
mBio; 2018 Jun; 9(3):. PubMed ID: 29921669
[TBL] [Abstract][Full Text] [Related]
10. Promoter sequence of Shiga toxin 2 (Stx2) is recognized in vivo, leading to production of biologically active Stx2.
Bentancor LV; Mejías MP; Pinto A; Bilen MF; Meiss R; Rodriguez-Galán MC; Baez N; Pedrotti LP; Goldstein J; Ghiringhelli PD; Palermo MS
mBio; 2013 Oct; 4(5):e00501-13. PubMed ID: 24085779
[TBL] [Abstract][Full Text] [Related]
11. The effect of probiotics and organic acids on Shiga-toxin 2 gene expression in enterohemorrhagic Escherichia coli O157:H7.
Carey CM; Kostrzynska M; Ojha S; Thompson S
J Microbiol Methods; 2008 May; 73(2):125-32. PubMed ID: 18328583
[TBL] [Abstract][Full Text] [Related]
12. Serum insulin-like growth factor-binding protein 2 levels as an indicator for disease severity in enterohemorrhagic
Tasaki Y; Inoue N; Shimizu M; Sugimoto N; Ishikawa S; Mizuta M; Yokoyama T; Kuroda M; Ohta K; Yachie A; Wada T
Ren Fail; 2021 Dec; 43(1):382-387. PubMed ID: 33641616
[TBL] [Abstract][Full Text] [Related]
13. Enterohemorrhagic Escherichia coli as causes of hemolytic uremic syndrome in the Czech Republic.
Marejková M; Bláhová K; Janda J; Fruth A; Petráš P
PLoS One; 2013; 8(9):e73927. PubMed ID: 24040117
[TBL] [Abstract][Full Text] [Related]
14. The Fatal Role of Enterohaemorrhagic Escherichia coli Shiga Toxin-associated Extracellular Vesicles in Host Cells.
Lee KS; Park JY; Jeong YJ; Lee MS
J Microbiol; 2023 Aug; 61(8):715-727. PubMed ID: 37665555
[TBL] [Abstract][Full Text] [Related]
15. Critical roles for stx2, eae, and tir in enterohemorrhagic Escherichia coli-induced diarrhea and intestinal inflammation in infant rabbits.
Ritchie JM; Thorpe CM; Rogers AB; Waldor MK
Infect Immun; 2003 Dec; 71(12):7129-39. PubMed ID: 14638803
[TBL] [Abstract][Full Text] [Related]
16. Synbiotic-like effect of linoleic acid overproducing
Tabashsum Z; Peng M; Bernhardt C; Patel P; Carrion M; Biswas D
Gut Pathog; 2019; 11():41. PubMed ID: 31372184
[TBL] [Abstract][Full Text] [Related]
17. Shiga toxin-negative attaching and effacing Escherichia coli: distinct clinical associations with bacterial phylogeny and virulence traits and inferred in-host pathogen evolution.
Bielaszewska M; Middendorf B; Köck R; Friedrich AW; Fruth A; Karch H; Schmidt MA; Mellmann A
Clin Infect Dis; 2008 Jul; 47(2):208-17. PubMed ID: 18564929
[TBL] [Abstract][Full Text] [Related]
18. Enterohemorrhagic Escherichia coli suppresses inflammatory response to cytokines and its own toxin.
Bellmeyer A; Cotton C; Kanteti R; Koutsouris A; Viswanathan VK; Hecht G
Am J Physiol Gastrointest Liver Physiol; 2009 Sep; 297(3):G576-81. PubMed ID: 19556613
[TBL] [Abstract][Full Text] [Related]
19. [Enterohemorrhagic Escherichia coli in hemolytic uremic syndrome in Chilean children. Evaluation of different technics in the diagnosis of the infection].
Prado V; Cordero J; Garreaud C; Olguin H; Arellano C; Nachar CL; Misraji A; Martínez J; Tous M; Rivas M
Rev Med Chil; 1995 Jan; 123(1):13-22. PubMed ID: 7569441
[TBL] [Abstract][Full Text] [Related]
20. Phylogenetic analysis and Shiga toxin production profiling of Shiga toxin-producing/enterohemorrhagic Escherichia coli clinical isolates.
Li R; Harada T; Honjoh K; Miyamoto T
Microb Pathog; 2010 Nov; 49(5):246-51. PubMed ID: 20558273
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
